Canada on February 26 approved AstraZeneca’s Covid-19 vaccine, including the version produced by the Serum Institute of India, and 500,000 doses are due to arrive next week.
The vaccine is the third to be approved by Health Canada following the December approval of vaccines developed by Pfizer Inc with BioNTech SE and Moderna Inc.
“With Pfizer, Moderna, and now AstraZeneca, Canada will get more than 6.5 million doses before the end of March,” Prime Minister Justin Trudeau told reporters. “And there will be tens of millions more doses to come between April and June.”
Canada has ordered 20 million doses of the vaccine from AstraZeneca, and is due to receive 1.9 million through COVAX – the international initiative set up to provide equitable access to vaccines – in the first half of the year.
On Friday, Canada said it had secured an additional 2 million doses through its agreement with Verity Pharmaceuticals Canada Inc and the Serum Institute of India.
